Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 6
2011 10
2012 14
2013 13
2014 12
2015 4
2016 9
2017 10
2018 3
2019 7
2020 7
2021 7
2022 10
2023 14
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 29593457

101 results

Results by year

Filters applied: . Clear all
Page 1
[Mobilization of peripheral blood stem cells with plerixafor in poor mobilizer patients].
Sancho JM, Duarte R, Medina L, Querol S, Marín P, Sureda A; en representación del Grupo de Trabajo de Movilización de la Sociedad Catalana de Hematología y Hemoterapia y de la Sociedad Catalano-Balear de Transfusión Sanguínea. Sancho JM, et al. Med Clin (Barc). 2016 Sep 2;147(5):223.e1-223.e7. doi: 10.1016/j.medcli.2016.05.019. Epub 2016 Jun 30. Med Clin (Barc). 2016. PMID: 27374031 Spanish.
Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
Nademanee AP, DiPersio JF, Maziarz RT, Stadtmauer EA, Micallef IN, Stiff PJ, Hsu FJ, Bridger G, Bolwell BJ. Nademanee AP, et al. Biol Blood Marrow Transplant. 2012 Oct;18(10):1564-72. doi: 10.1016/j.bbmt.2012.05.017. Epub 2012 Jun 6. Biol Blood Marrow Transplant. 2012. PMID: 22683613 Free article. Clinical Trial.
UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high-dose chemoradiotherapy for patients with malignancy.
Douglas KW, Gilleece M, Hayden P, Hunter H, Johnson PRE, Kallmeyer C, Malladi RK, Paneesha S, Pawson R, Quinn M, Raj K, Richardson D, Robinson S, Russell N, Snowden J, Sureda A, Tholouli E, Thomson K, Watts M, Wilson KM. Douglas KW, et al. J Clin Apher. 2018 Feb;33(1):46-59. doi: 10.1002/jca.21563. Epub 2017 Jun 20. J Clin Apher. 2018. PMID: 28631842 Review.
101 results